Jade Biosciences, Inc. Common Stock JBIO Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on assets | -65.3%-5.0pp | -60.3%+36.8pp | -97.1%-17.5pp | -79.6%+31.1pp | -110.7%-23.7pp | |
| Liquidity | ||||||
| Current ratio | 14.3×-6.8× | 21.1×+12.1× | 9×-1.3× | 10.3×-21.7× | 32×+26.2× | |
| Quick ratio | 14.3×-6.8× | 21.1×+12.1× | 9×-1.3× | 10.3×-21.7× | 32×+26.2× | |
| Cash ratio | 2.5×-2.9× | 5.3×+3.1× | 2.2×-8.0× | 10.2×-8.1× | 18.3×+12.5× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | —— | —— | —— | —— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -13×+1.6× | -14.6×+4.9× | -19.5×+6.0× | -25.5×+9.0× | -34.4×-9.1× | |
| Per Share | ||||||
| Book value per share | $5.13-51.6% | $10.60+134% | $4.53-36.1% | $7.09+127% | -$26.46-78.4% | |
| Valuation | ||||||
| Market capitalization | $1.33B+316% | —— | —— | —— | —— | |
| Enterprise value | $1.27B— | —— | —— | —— | —— | |
| Price / book | 4.5×— | —— | —— | —— | —— | |
| Earnings yield | -9.8%— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Jade Biosciences, Inc. Common Stock's ratios come from?
- Every ratio is computed from Jade Biosciences, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.